Recent studies have concentrated on elucidating the effects of NF-κB and its signaling mechanisms in regulating immune responses and inflammation, and have made it an appealing therapeutic target in various cancer immunotherapy studies [15]. The gene discussed is NFKB1; the disease is cancer.